Congenital antithrombin deficiency
Other Names for this Disease
- Antithrombin deficiency, congenital
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- ClinicalTrials.gov lists trials that are studying or have studied Congenital antithrombin deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
|Generic Name||Recombinant human antithrombin|
(GTC Biotherapeutics, Inc.)
The FDA has approved this product to be used in this manner.
|Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients.|
|More Information about this product||Drug Information Portal|